Restricted accessResearch articleFirst published online 2013-08
Engagement of CD14 Sensitizes Primary Monocytes to IFN-γ to Produce IL-12/23p40 and IL-23 Through p38 Mitogen-Activated Protein Kinase and Independent of the Janus Kinase/Signal Transducers and Activators of Transcription Signaling
Interferon (IFN)-γ is a potent stimulator of the IL-12 family Th1 cytokines, including IL-12/23p40 and IL-23, responsible for coordinating the innate and adaptive immune responses. Our results show that IFN-γ induced the production of IL-12/23p40 and IL-23p19 mRNA as well as IL-12p40 and IL-23 proteins in primary human monocytes isolated by positive selection through anti-CD14 microbeads. These results were confirmed by IFN-γ stimulation of CD14-activated monocytes resulting in IL-12/23p40 and IL-23 production. We investigated the signaling pathways governing the regulation of IL-23 and its subunits IL-23p40 and IL-23p19 following IFN-γ stimulation. We observed a differential regulation of IL-23p19, IL-12/23p40, and IL-23 following IFN-γ stimulation. IFN-γ-induced IL-23 and IL-12/23p40 expression was positively regulated by the p38 mitogen-activated protein kinases (MAPKs), independent of the Janus kinase (Jak)/signal transducers and activators of transcription (STAT) signaling. In contrast, IL-12 and IL-23 were negatively regulated by the Jak/STAT, phosphatidylinositol 3-kinase (PI3K), and the c-Jun-N-terminal kinase (JNK) MAPKs in IFN-γ-stimulated monocytes. Overall, our results suggest for the first time a differential positive regulation of IL-12p40 and IL-23 by p38 MAPKs independent of the Jak/STAT pathways and negative regulation by the Jak/STAT, JNK, and PI3K pathways in CD14-activated primary human monocytes stimulated with IFN-γ.
Get full access to this article
View all access options for this article.
References
1.
AggarwalS, GhilardiN, XieMH, de SauvageFJ, GurneyAL. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem, 278,3:1910–1914.
2.
Al-SalleehF, PetroTM. 2008. Promoter analysis reveals critical roles for SMAD-3 and ATF-2 in expression of IL-23 p19 in macrophages. J Immunol, 181,7:4523–4533.
3.
BeckerC, WirtzS, MaX, BlessingM, GallePR, NeurathMF. 2001. Regulation of IL-12 p40 promoter activity in primary human monocytes: roles of NF-kappaB, CCAAT/enhancer-binding protein beta, and PU.1 and identification of a novel repressor element (GA-12) that responds to IL-4 and prostaglandin E(2)J Immunol, 167,5:2608–2618.
4.
BrentanoF, OspeltC, StanczykJ, GayRE, GayS, KyburzD. 2009. Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis. Ann Rheum Dis, 68,1:143–150.
5.
BuscaA, SaxenaM, KumarA. 2012. Critical role for antiapoptotic bcl-xL and mcl-1 in human macrophage survival and cellular IAP1/2 (cIAP1/2) in resistance to HIV-vpr-induced apoptosis. J Biol Chem, 287,18:15118–15133.
6.
ButcharJP, ParsaKV, MarshCB, TridandapaniS. 2008. IFNgamma enhances IL-23 production during Francisella infection of human monocytes. FEBS Lett, 582,7:1044–1048.
7.
ButcharJP, RajaramMV, GanesanLP, ParsaKV, ClayCD, SchlesingerLS, TridandapaniS. 2007. Francisella tularensis induces IL-23 production in human monocytes. J Immunol, 178,7:4445–4454.
8.
CarmodyRJ, RuanQ, LiouHC, ChenYH. 2007. Essential roles of c-rel in TLR-induced IL-23 p19 gene expression in dendritic cells. J Immunol, 178,1:186–191.
9.
CarraG, GerosaF, TrinchieriG. 2000. Biosynthesis and posttranslational regulation of human IL-12. J Immunol, 164,9:4752–4761.
10.
CuaDJ, SherlockJ, ChenY, MurphyCA, JoyceB, SeymourB, LucianL, ToW, KwanS, ChurakovaTet al.2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature, 421,6924:744–748.
11.
DebA, HaqueSJ, MogensenT, SilvermanRH, WilliamsBR. 2001. RNA-dependent protein kinase PKR is required for activation of NF-kappa B by IFN-gamma in a STAT1-independent pathway. J Immunol, 166,10:6170–6178.
12.
DingC, XuJ, LiJ. 2008. ABT-874, a fully human monoclonal anti-IL-12/IL-23 antibody for the potential treatment of autoimmune diseases. Curr Opin Investig Drugs, 9,5:515–522.
13.
DobrevaZG, StanilovaSA, MitevaLD. 2008. Differences in the inducible gene expression and protein production of IL-12p40, IL-12p70 and IL-23: involvement of p38 and JNK kinase pathways. Cytokine, 43,1:76–82.
14.
EichbaumQG, IyerR, RavehDP, MathieuC, EzekowitzRA. 1994. Restriction of interferon gamma responsiveness and basal expression of the myeloid human fc gamma R1b gene is mediated by a functional PU.1 site and a transcription initiator consensus. J Exp Med, 179,6:1985–1996.
15.
ElkordE, WilliamsPE, KynastonH, RowbottomAW. 2005. Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells. Immunology, 114,2:204–212.
16.
FariesMB, BedrosianI, XuS, KoskiG, RorosJG, MoiseMA, NguyenHQ, EngelsFH, CohenPA, CzernieckiBJ. 2001. Calcium signaling inhibits interleukin-12 production and activates CD83(+) dendritic cells that induce Th2 cell development. Blood, 98,8:2489–2497.
17.
GautierG, HumbertM, DeauvieauF, ScuillerM, HiscottJ, BatesEE, TrinchieriG, CauxC, GarroneP. 2005. A type I interferon autocrine-paracrine loop is involved in toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med, 201,9:1435–1446.
18.
GeeK, GuzzoC, Che MatNF, MaW, KumarA. 2009. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets, 8,1:40–52.
19.
GeeK, KozlowskiM, KryworuchkoM, Diaz-MitomaF, KumarA. 2001. Differential effect of IL-4 and IL-13 on CD44 expression in the burkitt's lymphoma B cell line BL30/B95-8 and in epstein-barr virus (EBV) transformed human B cells: loss of IL-13 receptors on burkitt's lymphoma B cells. Cell Immunol, 211,2:131–142.
20.
GeeK, LimW, MaW, NandanD, Diaz-MitomaF, KozlowskiM, KumarA. 2002. Differential regulation of CD44 expression by lipopolysaccharide (LPS) and TNF-alpha in human monocytic cells: distinct involvement of c-jun N-terminal kinase in LPS-induced CD44 expression. J Immunol, 169,10:5660–5672.
21.
GilMP, BohnE, O'GuinAK, RamanaCV, LevineB, StarkGR, VirginHW, SchreiberRD. 2001. Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci U S A, 98,12:6680–6685.
22.
GoughDJ, SabapathyK, KoEY, ArthurHA, SchreiberRD, TrapaniJA, ClarkeCJ, JohnstoneRW. 2007. A novel c-jun-dependent signal transduction pathway necessary for the transcriptional activation of interferon gamma response genes. J Biol Chem, 282,2:938–946.
23.
HalfterUM, DerbyshireZE, VaillancourtRR. 2005. Interferon-gamma-dependent tyrosine phosphorylation of MEKK4 via Pyk2 is regulated by annexin II and SHP2 in keratinocytes. Biochem J, 388,Pt 1:17–28.
24.
HanadaT, TanakaK, MatsumuraY, YamauchiM, NishinakamuraH, AburataniH, MashimaR, KuboM, KobayashiT, YoshimuraA. 2005. Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene. J Immunol, 174,7:4325–4332.
25.
HappelKI, ZhengM, YoungE, QuintonLJ, LockhartE, RamsayAJ, ShellitoJE, SchurrJR, BagbyGJ, NelsonSet al.2003. Cutting edge: roles of toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol, 170,9:4432–4436.
26.
HaradaH, TakahashiE, ItohS, HaradaK, HoriTA, TaniguchiT. 1994. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol Cell Biol, 14,2:1500–1509.
27.
HuJ, RoySK, ShapiroPS, RodigSR, ReddySP, PlataniasLC, SchreiberRD, KalvakolanuDV. 2001. ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma. J Biol Chem, 276,1:287–289.
28.
HunterCA. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol, 5,7:521–523.
29.
KamadaN, HisamatsuT, OkamotoS, ChinenH, KobayashiT, SatoT, SakurabaA, KitazumeMT, SugitaA, KoganeiKet al.2008. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J Clin Invest, 118,6:2269–2280.
KleinschekMA, MullerU, BrodieSJ, StenzelW, KohlerG, BlumenscheinWM, StraubingerRK, McClanahanT, KasteleinRA, AlberG. 2006. IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J Immunol, 176,2:1098–1106.
32.
KruegerGG, LangleyRG, LeonardiC, YeildingN, GuzzoC, WangY, DooleyLT, LebwohlM. CNTO 1275 Psoriasis Study Group. 2007. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med, 356,6:580–592.
LeeE, TrepicchioWL, OestreicherJL, PittmanD, WangF, ChamianF, DhodapkarM, KruegerJG. 2004. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med, 199,1:125–130.
36.
LiY, ChuN, HuA, GranB, RostamiA, ZhangGX. 2008. Inducible IL-23p19 expression in human microglia via p38 MAPK and NF-kappaB signal pathways. Exp Mol Pathol, 84,1:1–8.
37.
LiuJ, CaoS, HermanLM, MaX. 2003. Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1. J Exp Med, 198,8:1265–1276.
38.
MaW, GeeK, LimW, ChambersK, AngelJB, KozlowskiM, KumarA. 2004. Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-jun N-terminal kinase, the activation protein-1, and NF-kappa B transcription factors. J Immunol, 172,1:318–330.
39.
MahtaniKR, BrookM, DeanJL, SullyG, SaklatvalaJ, ClarkAR. 2001. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol, 21,19:6461–6469.
40.
MaruyamaS, SumitaK, ShenH, KanohM, XuX, SatoM, MatsumotoM, ShinomiyaH, AsanoY. 2003. Identification of IFN regulatory factor-1 binding site in IL-12 p40 gene promoter. J Immunol, 170,2:997–1001.
MurphyCA, LangrishCL, ChenY, BlumenscheinW, McClanahanT, KasteleinRA, SedgwickJD, CuaDJ. 2003. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med, 198,12:1951–1957.
43.
MurphyTL, ClevelandMG, KuleszaP, MagramJ, MurphyKM. 1995. Regulation of interleukin 12 p40 expression through an NF-kappa B half-site. Mol Cell Biol, 15,10:5258–5267.
44.
OppmannB, LesleyR, BlomB, TimansJC, XuY, HunteB, VegaF, YuN, WangJ, SinghKet al.2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity, 13,5:715–725.
45.
PetroTM. 2005. ERK-MAP-kinases differentially regulate expression of IL-23 p19 compared with p40 and IFN-beta in Theiler's virus-infected RAW264.7 cells. Immunol Lett, 97,1:47–53.
46.
PlevySE, GemberlingJH, HsuS, DornerAJ, SmaleST. 1997. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and rel proteins. Mol Cell Biol, 17,8:4572–4588.
47.
QingY, StarkGR. 2004. Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J Biol Chem, 279,40:41679–41685.
48.
RamanaCV, GilMP, SchreiberRD, StarkGR. 2002. Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol, 23,2:96–101.
49.
RaniMR, HibbertL, SizemoreN, StarkGR, RansohoffRM. 2002. Requirement of phosphoinositide 3-kinase and akt for interferon-beta-mediated induction of the beta-R1 (SCYB11) gene. J Biol Chem, 277,41:38456–38461.
50.
RosesRE, XuS, XuM, KoldovskyU, KoskiG, CzernieckiBJ. 2008. Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists. J Immunol, 181,7:5120–5127.
51.
RutaultK, HazzalinCA, MahadevanLC. 2001. Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-alpha (TNF-alpha) mRNA induction: evidence for selective destabilization of TNF-alpha transcripts. J Biol Chem, 276,9:6666–6674.
52.
SaxenaM, BuscaA, PandeyS, KryworuchkoM, KumarA. 2011. CpG protects human monocytic cells against HIV-vpr-induced apoptosis by cellular inhibitor of apoptosis-2 through the calcium-activated JNK pathway in a TLR9-independent manner. J Immunol, 187,11:5865–5878.
53.
SheikhSZ, MatsuokaK, KobayashiT, LiF, RubinasT, PlevySE. 2010. Cutting edge: IFN-gamma is a negative regulator of IL-23 in murine macrophages and experimental colitis. J Immunol, 184,8:4069–4073.
54.
SunD, DingA. 2006. MyD88-mediated stabilization of interferon-gamma-induced cytokine and chemokine mRNA. Nat Immunol, 7,4:375–381.
55.
UddinS, MajchrzakB, WangPC, ModiS, KhanMK, FishEN, PlataniasLC. 2000. Interferon-dependent activation of the serine kinase PI 3′-kinase requires engagement of the IRS pathway but not the stat pathway. Biochem Biophys Res Commun, 270,1:158–162.
56.
UtsugiM, DobashiK, IshizukaT, EndouK, HamuroJ, MurataY, NakazawaT, MoriM. 2003. C-jun N-terminal kinase negatively regulates lipopolysaccharide-induced IL-12 production in human macrophages: role of mitogen-activated protein kinase in glutathione redox regulation of IL-12 production. J Immunol, 171,2:628–635.
57.
UtsugiM, DobashiK, IshizukaT, KawataT, HisadaT, ShimizuY, OnoA, MoriM. 2006. Rac1 negatively regulates lipopolysaccharide-induced IL-23 p19 expression in human macrophages and dendritic cells and NF-kappaB p65 trans activation plays a novel role. J Immunol, 177,7:4550–4557.
58.
ValledorAF, ArpaL, Sanchez-TilloE, ComaladaM, CasalsC, XausJ, CaellesC, LloberasJ, CeladaA. 2008a. IFN-{gamma}-mediated inhibition of MAPK phosphatase expression results in prolonged MAPK activity in response to M-CSF and inhibition of proliferation. Blood, 112,8:3274–3282.
59.
ValledorAF, Sanchez-TilloE, ArpaL, ParkJM, CaellesC, LloberasJ, CeladaA. 2008b. Selective roles of MAPKs during the macrophage response to IFN-gamma. J Immunol, 180,7:4523–4529.
60.
WaiblerZ, KalinkeU, WillJ, JuanMH, PfeilschifterJM, RadekeHH. 2007. TLR-ligand stimulated interleukin-23 subunit expression and assembly is regulated differentially in murine plasmacytoid and myeloid dendritic cells. Mol Immunol, 44,7:1483–1489.
61.
YangCS, SongCH, LeeJS, JungSB, OhJH, ParkJ, KimHJ, ParkJK, PaikTH, JoEK. 2006. Intracellular network of phosphatidylinositol 3-kinase, mammalian target of the rapamycin/70 kDa ribosomal S6 kinase 1, and mitogen-activated protein kinases pathways for regulating mycobacteria-induced IL-23 expression in human macrophages. Cell Microbiol, 8,7:1158–1171.
62.
YenD, CheungJ, ScheerensH, PouletF, McClanahanT, McKenzieB, KleinschekMA, OwyangA, MattsonJ, BlumenscheinWet al.2006. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest, 116,5:1310–1316.
